Small-interfering RNA-eluting surfaces as a novel concept for intravascular local gene silencing

Molecular Medicine

Volumn 17, Issue 11, 2011, Pages 1213-1222

  Nolte, Andrea ^a   Walker, Tobias ^a   Schneider, Martina ^a   Kray, Oya ^a   Avci Adali, Meltem ^a   Ziemer, Gerhard ^a   Wendel, Hans Peter ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATIN; POLYETHYLENEIMINE; SMALL INTERFERING RNA;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG ELUTING STENT; ENDOTHELIUM CELL; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RNA HYBRIDIZATION; RNA INTERFERENCE;

BLOOD VESSEL PROSTHESIS; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; CULTURE MEDIA; DRUG-ELUTING STENTS; E-SELECTIN; ENDOTHELIAL CELLS; FLUORESCENT DYES; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; POLYETHYLENEIMINE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SERUM; TRANSFECTION;

EID: 82855164053     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2011.00143     Document Type: Article

References (49)

1. Greenhalgh J, et al. (2010) Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes. Cochrane Database Syst. Rev. 5:CD004587.
2. Wendel HP, Avci-Adali M, Ziemer G. (2010) Endothelial progenitor cell capture stents: hype or hope? Int. J. Cardiol. 5;145:115-7
3. Dorsett Y, Tuschl T. (2004) siRNAs: applications in functional genomics and potential as therapeutics. Nat. Rev. Drug. Discov. 3:318-29.
4. Elbashir SM, et al. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:494-8.
5. Fire A, et al. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391:806-811.
6. Meister G, Tuschl T. (2004) Mechanisms of gene silencing by double-stranded RNA. Nature. 431:343-9.
7. Chi JT, et al. (2003) Genomewide view of gene silencing by small interfering RNAs. Proc. Natl. Acad. Sci. U. S. A. 100:6343-6.
8. Hassan A, et al. (2005) Small interfering RNAmediated functional silencing of vasopressin V2 receptors in the mouse kidney. Physiol. Genomics. 21:382-8.
9. Shimizu H, Fujita T. (2011) New short interfering RNA-based therapies for glomerulonephritis. Nat. Rev. Nephrol. 7:407-15
10. Tagalakis AD, He L, Saraiva L, Gustafsson KT, Hart SL. (2011) Receptor-targeted liposomepeptide nanocomplexes for siRNA delivery. Biomaterials. 2:6302-15
11. Kato M, et al. (2009) The targeting of cyclophilin D by RNAi as a novel cardioprotective therapy: evidence from two-photon imaging. Cardiovasc. Res. 83:335-44.
12. Valentim L, et al. (2006) Urocortin inhibits Beclin1- mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury. J. Mol. Cell. Cardiol. 40:846-52.
13. Yin C, Xi L, Wang X, Eapen M, Kukreja RC. (2005) Silencing heat shock factor 1 by small interfering RNA abrogates heat shock-induced cardioprotection against ischemia-reperfusion injury in mice. J. Mol. Cell. Cardiol. 39:681-9.
14. Zheng X, et al. (2009) Novel small interfering RNA-containing solution protecting donor organs in heart transplantation. Circulation. 120:1099-107, 1091 p following 1107.
15. Akhtar S, Benter IF. (2007) Nonviral delivery of synthetic siRNAs in vivo. J. Clin. Invest. 117:3623-32.
16. Bumcrot D, Manoharan M, Koteliansky V, Sah DW. (2006) RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat. Chem. Biol. 2:711-9.
17. Lin X, et al. (2011) A robust in vivo positive-readout system for monitoring siRNA delivery to xenograft tumors. RNA. 17:603-12.
18. Shim MS, Kwon YJ. (2010) Efficient and targeted delivery of siRNA in vivo. FEBS J. 277:4814-27.
19. Walker T, et al. (2007) Inhibition of adhesion molecule expression on human venous endothelial cells by non-viral siRNA transfection. J. Cell. Mol. Med. 11:139-47.
20. Collins T, et al. (1991) Structure and chromosomal location of the gene for endothelial-leukocyte adhesion molecule 1. J Biol. Chem. 266:2466-73.
21. Zhao QQ, et al. (2009) N/P ratio significantly influences the transfection efficiency and cytotoxicity of a polyethylenimine/chitosan/DNA complex. Biol. Pharm. Bull. 32:706-710.
22. Leng Q, Woodle MC, Lu PY, Mixson AJ. (2009) Advances in systemic siRNA delivery. Drugs Future. 34:721.
23. Werth S, et al. (2006) A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes. J. Control Release. 112:257-70.
24. Boussif O, et al. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U. S. A. 92:7297-301.
25. Finsinger D, Remy JS, Erbacher P, Koch C, Plank C. (2000) Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery. Gene Ther. 7:1183-92.
26. Berg MC, Zhai L, Cohen RE, Rubner MF. (2006) Controlled drug release from porous polyelectrolyte multilayers. Biomacromolecules 7:357-64.
27. Thierry B, et al. (2005) Delivery platform for hydrophobic drugs: prodrug approach combined with self-assembled multilayers. J. Am. Chem. Soc. 127:1626-7.
28. Thierry B, Winnik FM, Merhi Y, Silver J, Tabrizian M. (2003) Bioactive coatings of endovascular stents based on polyelectrolyte multilayers. Biomacromolecules. 4:1564-71.
29. Wood KC, Chuang HF, Batten RD, Lynn DM, Hammond PT. (2006) Controlling interlayer diffusion to achieve sustained, multiagent delivery from layer-by-layer thin films. Proc. Natl. Acad. Sci. U. S. A. 103:10207-12.
30. Blacklock J, You YZ, Zhou QH, Mao G, Oupicky D. (2009) Gene delivery in vitro and in vivo from bioreducible multilayered polyelectrolyte films of plasmid DNA. Biomaterials. 30:939-50.
31. Jessel N, et al. (2006) Multiple and time-scheduled in situ DNA delivery mediated by beta-cyclodextrin embedded in a polyelectrolyte multilayer. Proc. Natl. Acad. Sci. U. S. A. 103:8618-21.
32. Jewell CM, Zhang J, Fredin NJ, Lynn DM. (2005) Multilayered polyelectrolyte films promote the direct and localized delivery of DNA to cells. J. Control Release. 106:214-23.
33. Meyer F, Ball V, Schaaf P, Voegel JC, Ogier J. (2006) Polyplex-embedding in polyelectrolyte multilayers for gene delivery. Biochim. Biophys. Acta. 1758:419-22.
34. Zhang J, Chua LS, Lynn DM. (2004) Multilayered thin films that sustain the release of functional DNA under physiological conditions. Langmuir. 20:8015-21.
35. Dimitrova M, et al. (2008) Sustained delivery of siRNAs targeting viral infection by cell-degradable multilayered polyelectrolyte films. Proc. Natl. Acad. Sci. U. S. A. 105:16320-5.
36. Neumann B, et al. (2006) High-throughput RNAi screening by time-lapse imaging of live human cells. Nat. Methods. 3:385-90.
37. Nolte A, et al. (2009) Optimized basic conditions are essential for successful siRNA transfection into primary endothelial cells. Oligonucleotides. 19:141-50.
38. Marin V, Kaplanski G, Gres S, Farnarier C, Bongrand P. (2001) Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells. J. Immunol. Methods. 254:183-90.
39. Relou IA, Damen CA, van der Schaft DW, Groenewegen G, Griffioen AW. (1998) Effect of culture conditions on endothelial cell growth and responsiveness. Tissue Cell. 30:525-30.
40. Walker T, Wendel HP, Tetzloff L, Heidenreich O, Ziemer G. (2005) Suppression of ICAM-1 in human venous endothelial cells by small interfering RNAs. Eur. J. Cardiothorac. Surg. 28:816-20.
41. Rozen S, Skaletsky H. (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132:365-86.
42. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7:678-89.
43. Ley K, Miller YI, Hedrick CC. (2011) Monocyte and macrophage dynamics during atherogenesis. Arterioscler. Thromb. Vasc. Biol. 31:1506-16.
44. Bigi A, Cojazzi G, Panzavolta S, Roveri N, Rubini K. (2002) Stabilization of gelatin films by crosslinking with genipin. Biomaterials. 23:4827-32.
45. Walker T, et al. (2009) Graft protection in bypass surgery: siRNA-mediated silencing of adhesion molecules. Oligonucleotides. 19:15-21.
46. Dykxhoorn DM, Novina CD, Sharp PA. (2003) Killing the messenger: short RNAs that silence gene expression. Nat. Rev. Mol. Cell. Biol. 4:457-67.
47. Tepe G, et al. (2008) Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N. Engl. J. Med. 358:689-99.
48. Werk M, et al. (2008) Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 118:1358-65.
49. San Juan A, et al. (2009) Development of a functionalized polymer for stent coating in the arterial delivery of small interfering RNA. Biomacromolecules. 10:3074-80.